You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 23, 2024

CLINICAL TRIALS PROFILE FOR OXYCONTIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for OXYCONTIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00254631 ↗ Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures Completed Rambam Health Care Campus Phase 4 2007-04-01 We would like to check whether pre-operative administration of an oral controlled-release opioid formulation (Oxycodone hydrochloride (OxyContin)) could result in a clear effect of preemptive analgesia.
NCT00399048 ↗ An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) Completed Alza Corporation, DE, USA Phase 3 1969-12-31 The purpose of this study was to characterize the effectiveness and safety of OROS hydromorphone HCL and OxyContin in patients with chronic osteoarthritis (OA) of the knee or hip who are receiving chronic nonsteroidal anti-inflammatory drug (NSAID) or other nonsteroidal, non-opioid analgesic (ie, acetaminophen or aspirin) therapy.
NCT00414453 ↗ Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis Terminated Endo Pharmaceuticals Phase 4 2007-01-01 This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for OXYCONTIN

Condition Name

Condition Name for OXYCONTIN
Intervention Trials
Healthy 9
Pain 8
Pain, Postoperative 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for OXYCONTIN
Intervention Trials
Pain, Postoperative 13
Chronic Pain 5
Osteoarthritis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for OXYCONTIN

Trials by Country

Trials by Country for OXYCONTIN
Location Trials
United States 139
Korea, Republic of 4
China 4
Israel 3
Norway 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for OXYCONTIN
Location Trials
Texas 9
New York 7
California 6
Missouri 6
Utah 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for OXYCONTIN

Clinical Trial Phase

Clinical Trial Phase for OXYCONTIN
Clinical Trial Phase Trials
Phase 4 14
Phase 3 11
Phase 2 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for OXYCONTIN
Clinical Trial Phase Trials
Completed 46
Recruiting 5
Terminated 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OXYCONTIN

Sponsor Name

Sponsor Name for OXYCONTIN
Sponsor Trials
Purdue Pharma LP 10
Mundipharma (China) Pharmaceutical Co. Ltd 3
Endo Pharmaceuticals 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for OXYCONTIN
Sponsor Trials
Other 36
Industry 36
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.